Canada’s health department is now sharing study results on new drugs and treatments online. Transparency advocates want the United States to do the same.

A behavioral therapy called pivotal response treatment may boost the communication skills of autistic children with language delay better than do standard speech and autism therapies.

A drug that treats tumors and epilepsy in people with tuberous sclerosis complex does not boost their intelligence or ease autism traits.

Clinical trials of autism treatments rarely use a consistent set of tools to measure efficacy, making it tough to compare the treatments.

Following pushback from scientists, the U.S. National Institutes of Health has issued a two-year delay on a rule requiring basic researchers to register their studies as clinical trials.

Envisioned as bioRxiv’s clinical cousin, the new preprint server medRxiv hosts unpublished manuscripts describing original medical research.